Related Experiment Videos
[Aspects for hormone therapy in prostate cancer]
Zeitschrift Fur Urologie Und Nephrologie
|September 1, 1981
Summary
Antiandrogenic hormone therapy offers palliative prostate cancer treatment by affecting testosterone. Curative therapies like surgery or radiotherapy are essential due to uncertain hormone therapy effectiveness.
Area of Science:
- Oncology
- Endocrinology
- Urology
Context:
- Prostate carcinoma treatment landscape.
- Hormone therapy as a primary palliative approach.
- Understanding testosterone metabolism in prostate cancer.
Purpose:
- To critically review current antiandrogenic hormone therapy for prostate cancer.
- To explain the extra- and intraprostatic effects of testosterone.
- To highlight the need for curative treatment options.
Summary:
- Antiandrogenic hormone therapy is a main palliative treatment for prostate carcinoma.
- The study explains testosterone metabolism and its effects.
- Current hormone receptor research is critically assessed.
Impact:
- Emphasizes the limitations of palliative hormone therapy.
- Underscores the necessity of curative treatments (radical surgery, radiotherapy).
- Informs clinical decisions regarding prostate cancer management.